DOCSLIB.ORG

Pharmacology

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Pharmacology GraduateSchool of MedicalSciences PHARMACOLOGY A partnership with the Sloan Kettering Institute PROGRAM OVERVIEW The Pharmacology PhD program is unique in that it trains students in the underlying scientific foundations of modern pharmacology. FOUNDATIONS: Mission The research activities of the Weill Cornell Chemical Biology Pharmacology Program faculty cover broad areas of modern pharmacological sciences. Faculty carry out research in cancer pharmacology, neuropharmacology, cardiovascular pharmacology, Radiochemistry drug metabolism, toxicology, proteomics, molecular pharmacology, receptors and signal transduction, chemical biology, radiochemistry, drug design, molecular imaging, nanotechnology, Drug Design and immunotherapy. A major mission of the Pharmacology Program faculty is to provide research training to Ph.D. students and to postdoctoral fellows that is thorough, intense, exciting Molecular Biology and state of the art. Required Courses Molecular Imaging • Essential Principles of Pharmacology / Pharmacology “BootCamp” WCGS Overview • Principles of Pharmacology I: Chemical Biology • Collaboration of two Nanotechnology leading research institutions – • Principles of Pharmacology II: Signal Weill Cornell Medical College Transduction (WCMC) and Sloan-Kettering Institute (SKI) • Principles of Pharmacology III: Principles and Immunotherapy Systems Pharmacology • Over 285 research faculty • Principles of Pharmacology IV: Molecular members, selected for their Pharmacology of Cancer research excellence and academic mentorship • Next-Gen Methods for Neuroscience and RNA Biology Pharmacology Why WCGS? • Responsible Conduct of Research • Location: New York City’s Cell Signaling and • Neuropharmacology I: Genes, Drugs and Scientific Corridor on the Therapeutics Behavior Upper East Side • Neuropharmacology II: Neuropeptides and Pain • Research: Drug Discovery, and Drugs of Abuse Cancer Research, Stem Cell Research and Translational • Pharmacology Seminar Series Medicine • Stipend: $41,000 per academic year, full tuition Application scholarship and subsidized housing All applications and materials can be submitted online at http://bit.ly/WCGS-Apply gradschool.weill.cornell.edu 1300 YORK AVENUE, NEW YOR, NY 10065 PHARMACOLOGY Year Year Year Year Year Timeline 01 02 03 04 05... Lab rotations (3) Core curriculum courses Graduate research seminar Attendance at Pharmacology Seminars Presentation of talks and posters at school-wide events and program symposia Quantitative Biology course (required school-wide course) Select research focus and Faculty Special Committee (thesis mentor plus two other faculty member experts in More than 40 faculty relevant research field) members, who are members of Weill Cornell Medical Admission to Doctoral College and the Sloan- Candidacy Examination (ACE) test (research proposal and oral examination) Kettering Institute (SKI, part of Memorial Sloan-Kettering Submit Fellowship application Cancer Center). One elective Course (two quarters) Lab research Careers Meetings with Special Committee WCGS is greatly focused on PhD thesis research student outcomes and postgraduate career Defend PhD thesis opportunities. We regularly host visits and talks by alumni, recruiters and career advisors, Links to discuss career opportunities and to help you develop the For More Information: http://bit.ly/WCPharm skills you need to succeed To Apply: http://bit.ly/WCGS-Apply when looking towards your Questions? [email protected] next steps. In addition, WCGS sponsors a Career Pathways Seminar series and is a sponsor of the Tri-Institutional Career Symposium and the What Can You Be with a PhD? Career Symposium. Graduates typically go on to postdoctoral and research associate positions at top- tier laboratories before embarking on careers in fields such as academia, pharma, biotechnology, consulting, government work, and patent law. GraduateSchool of MedicalSciences 1300 YORK AVENUE, NEW YORK, NY 10065 A partnership with the Sloan Kettering Institute.
Load more

Recommended publications
  • Pharmacology
    Pharmacology New for 2020-2021 Competitor orientation deleted from ILC. Event Summary Pharmacology provides HOSA members with the opportunity to gain knowledge and skills regarding the area of healthcare concerned with uses, effects, and modes of actions of drugs. This competitive event consists of a written test with a tie-breaker essay question. This event aims to inspire members to learn about how drugs work in the body, proper administration, and adaptations for different patients and conditions. Dress Code Competitors must be in official HOSA uniform or proper business attire. Bonus points will be awarded for proper dress. General Rules 1. Competitors in this event must be active members of HOSA-Future Health Professionals, in good standing. 2. Secondary and Postsecondary/Collegiate divisions are eligible to compete in this event. 3. Competitors must be familiar with and adhere to the “General Rules and Regulations of the HOSA Competitive Events Program (GRR)." 4. All competitors shall report to the site of the event at the time designated for each round of competition. At ILC, competitor’s photo ID must be presented prior to ALL competition rounds. Official References • Fulcher, Soto and Fulcher. Pharmacology: Principles and Applications. Elsevier, Latest edition. • Ford, Susan and Sally Roach. Roach’s Introductory Clinical Pharmacology. Wolters Kluwer, Latest edition. Written Test 5. Test Instructions: The written test will consist of 100 multiple choice items in a maximum of 90 minutes. 6. Time Remaining Announcements: There will be a verbal announcement when there are 60 minutes, 30 minutes, 15 minutes, 5 minutes, and 1 minute remaining to complete the test.
    [Show full text]
  • Clinical Pharmacology 1: Phase 1 Studies and Early Drug Development
    Clinical Pharmacology 1: Phase 1 Studies and Early Drug Development Gerlie Gieser, Ph.D. Office of Clinical Pharmacology, Div. IV Objectives • Outline the Phase 1 studies conducted to characterize the Clinical Pharmacology of a drug; describe important design elements of and the information gained from these studies. • List the Clinical Pharmacology characteristics of an Ideal Drug • Describe how the Clinical Pharmacology information from Phase 1 can help design Phase 2/3 trials • Discuss the timing of Clinical Pharmacology studies during drug development, and provide examples of how the information generated could impact the overall clinical development plan and product labeling. Phase 1 of Drug Development CLINICAL DEVELOPMENT RESEARCH PRE POST AND CLINICAL APPROVAL 1 DISCOVERY DEVELOPMENT 2 3 PHASE e e e s s s a a a h h h P P P Clinical Pharmacology Studies Initial IND (first in human) NDA/BLA SUBMISSION Phase 1 – studies designed mainly to investigate the safety/tolerability (if possible, identify MTD), pharmacokinetics and pharmacodynamics of an investigational drug in humans Clinical Pharmacology • Study of the Pharmacokinetics (PK) and Pharmacodynamics (PD) of the drug in humans – PK: what the body does to the drug (Absorption, Distribution, Metabolism, Excretion) – PD: what the drug does to the body • PK and PD profiles of the drug are influenced by physicochemical properties of the drug, product/formulation, administration route, patient’s intrinsic and extrinsic factors (e.g., organ dysfunction, diseases, concomitant medications,
    [Show full text]
  • I. Antihistamines Seunghoon Han* Department of Clinical Pharmacology and Therapeutics, Seoul St
    2014;22(1):13-18 TCP Translational and Clinical Pharmacology http://dx.doi.org/10.12793/tcp.2014.22.1.13 Clinical Pharmacology Review for Primary Health Care Providers: I. Antihistamines Seunghoon Han* Department of Clinical Pharmacology and Therapeutics, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul 137-701, Korea *Correspondence: S. Han; Tel: +82-2-2258-7326, Fax: +82-2-2258-7876, E-mail: [email protected] Received 31 May 2014 Primary health care providers play a critical role in maintaining public health, and the appropri- Accepted 31 May 2014 ate use of pharmaceutical products is one of the major parts of their practice. This series of articles, pISSN: 2289-0882 entitled ‘Clinical Pharmacology Review for Primary Health Care Providers,’ is intended to help pri- mary health care providers select more appropriate prescriptions for frequently used drugs based on up-to-date information. We expect that this effort will contribute to improvements in public health and diminish unnecessary drug use. Introduction tion on the H1 receptor.[8] THERAPEU Antihistamines include some of the most frequently prescribed drugs in the primary health care environment for the symp- Generations and Classes tomatic relief of allergic diseases, the common cold, urticaria, Many primary health care providers are well-informed about T and insomnia.[1-5] The importance of antihistamines has been the different ‘generations’ of antihistamines but not about the ICS TU emphasized as the prevalence of target diseases increases.[6,7] different ‘classes’ characterized according to chemical structure. However, the appropriate use, clinical effectiveness, and target [1] This discrepancy seems reasonable because ‘inter-generation’ T populations for prescription of antihistamines are still a matter differences are more prominent than ‘inter-class’ differences.
    [Show full text]
  • Guidance for Reviewers Pharmacology/Toxicology Review Format
    Guidance for Reviewers Pharmacology/Toxicology Review Format U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Pharmacology/Toxicology May 2001 Guidance for Reviewers Pharmacology/Toxicology Review Format Additional copies are available from: Drug Information Branch (HFD-210) Center for Drug Evaluation and Research (CDER) 5600 Fishers Lane, Rockville, MD 20857, (Tel) 301-827-4570 Internet at http://www.fda.gov/der/guidance/index.htm U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Pharmacology/Toxicology May 2001 Guidance for Reviewers Table of Contents I. INTRODUCTION ....................................................................................................1 II. BACKGROUND.......................................................................................................1 III. DISCUSSION ...........................................................................................................1 A. IND REVIEW FORMAT ....................................................................................1 B. NDA REVIEW FORMAT...................................................................................1 IV. ATTACHMENTS .....................................................................................................1 A. IND REVIEW FORMAT ....................................................................................A-i B. NDA REVIEW FORMAT...................................................................................B-i
    [Show full text]
  • Department of Pharmacology (GRAD) 1
    Department of Pharmacology (GRAD) 1 faculty participate fully at all levels. The department has the highest DEPARTMENT OF level of NIH funding of all pharmacology departments and a great diversity of research areas is available to trainees. These areas PHARMACOLOGY (GRAD) include cell surface receptors, G proteins, protein kinases, and signal transduction mechanisms; neuropharmacology; nucleic acids, cancer, Contact Information and antimicrobial pharmacology; and experimental therapeutics. Cell and molecular approaches are particularly strong, but systems-level research Department of Pharmacology such as behavioral pharmacology and analysis of knock-in and knock-out Visit Program Website (http://www.med.unc.edu/pharm/) mice is also well-represented. Excellent physical facilities are available for all research areas. Henrik Dohlman, Chair Students completing the training program will have acquired basic The Department of Pharmacology offers a program of study that leads knowledge of pharmacology and related fields, in-depth knowledge in to the degree of doctor of philosophy in pharmacology. The curriculum is their dissertation research area, the ability to evaluate scientific literature, individualized in recognition of the diverse backgrounds and interests of mastery of a variety of laboratory procedures, skill in planning and students and the broad scope of the discipline of pharmacology. executing an important research project in pharmacology, and the ability The department offers a variety of research areas including to communicate results, analysis, and interpretation. These skills provide a sound basis for successful scientific careers in academia, government, 1. Receptors and signal transduction or industry. 2. Ion channels To apply to BBSP, students must use The Graduate School's online 3.
    [Show full text]
  • Biomolecules
    biomolecules Communication MBLinhibitors.com, a Website Resource Offering Information and Expertise for the Continued Development of Metallo-β-Lactamase Inhibitors Zishuo Cheng 1, Caitlyn A. Thomas 1, Adam R. Joyner 2, Robert L. Kimble 1, Aidan M. Sturgill 1 , Nhu-Y Tran 1, Maya R. Vulcan 1, Spencer A. Klinsky 1, Diego J. Orea 1, Cody R. Platt 2, Fanpu Cao 2, Bo Li 2, Qilin Yang 2, Cole J. Yurkiewicz 1, Walter Fast 3 and Michael W. Crowder 1,* 1 Department of Chemistry and Biochemistry, Miami University, Oxford, OH 45056, USA; [email protected] (Z.C.); [email protected] (C.A.T.); [email protected] (R.L.K.); [email protected] (A.M.S.); [email protected] (N.-Y.T.); [email protected] (M.R.V.); [email protected] (S.A.K.); [email protected] (D.J.O.); [email protected] (C.J.Y.) 2 Department of Computer Science and Software Engineering, Miami University, Oxford, OH 45056, USA; [email protected] (A.R.J.); [email protected] (C.R.P.); [email protected] (F.C.); [email protected] (B.L.); [email protected] (Q.Y.) 3 Division of Chemical Biology and Medicinal Chemistry, College of Pharmacy and the LaMontagne Center for Infectious Disease, University of Texas, Austin, TX 78712, USA; [email protected] * Correspondence: [email protected]; Tel.: +1-513-529-2813 Received: 17 February 2020; Accepted: 12 March 2020; Published: 16 March 2020 Abstract: In an effort to facilitate the discovery of new, improved inhibitors of the metallo-β-lactamases (MBLs), a new, interactive website called MBLinhibitors.com was developed.
    [Show full text]
  • To Undergraduate Studies in Chemistry, Chemical Engineering, and Chemical Biology College of Chemistry, University of California, Berkeley, 2011-12
    Guide to Undergraduate Studies in Chemistry, Chemical Engineering, and -2012 Chemical Biology College of Chemistry 2011 University of California, Berkeley Academic Calendar 2011-12 Fall Semester 2011 Tele-BEARS Begins April 11 Monday Fee Payment Due August 15 Monday Fall Semester Begins August 18 Thursday Welcome Events August 22-26 Monday-Friday Instruction Begins August 25 Thursday Labor Day Holiday September 5 Monday Veterans Day Holiday November 11 Friday Thanksgiving Holiday November 24-25 Thursday-Friday Formal Classes End December 2 Friday Reading/Review/Recitation Week December 5-9 Monday-Friday Final Examinations December 12-16 Monday-Friday Fall Semester Ends December 16 Friday Winter Holiday December 26-27 Monday-Tuesday New Year’s Holiday December 29-30 Thursday-Friday Spring Semester 2012 Tele-BEARS Begins October 17, 2011 Monday Spring Semester Begins January 10 Tuesday Fee Payment Due January 15 Sunday Martin Luther King Jr. Holiday January 16 Monday Instruction Begins January 17 Tuesday Presidents’ Day Holiday February 20 Monday Spring Recess March 26-30 Monday-Friday César Chávez Holiday March 30 Friday Cal Day To Be Determined Formal Classes End April 27 Friday Reading/Review/Recitation Week April 30-May 4 Monday-Friday Final Examinations May 7-11 Monday-Friday Spring Semester Ends May 11 Friday Summer Sessions 2012 Tele-BEARS Begins February 6 Monday First Six-Week Session May 21-June 29 Monday-Friday Memorial Day Holiday May 28 Monday Ten-Week Session June 4-August 10 Monday-Friday Eight-Week Session June 18-August
    [Show full text]
  • Pharmacology 101
    Pharmacology 101 Tyler Fischback, PharmD, BCPS, DPLA Clinical Pharmacy Manager Confluence Health Wenatchee, WA Objectives • Define Pharmacology, Pharmacokinetics and Pharmacodynamics • Understand how drug interactions work • Understand how some specific drugs behave in the body (opioids, benzodiazepines, amiodarone) • Apply pharmacology principles into practice Medication Errors and Adverse Drug Events • Error: An error of commission or omission at any step along the pathway that begins when a clinician prescribes a medication and ends when the patient actually received the medication. • ADE: Harm experienced by a patient as a result of exposure to a medication. ADE does not necessarily indicate an error or poor care. However, ~1/2 of ADEs are preventable. Anyone here ever seen a medication error or adverse drug event? Anyone here ever made a medication error? How many different prescription medications are available on the U.S. market? 1,000 So, it’s no surprise why we see so many problems………………… EXCEPT……. The real number is 10,000 Adverse Drug Events • ~1/3 of U.S. adults use 5 or more medications • Annually, ADE = 700,000 ER visits and 100,000 hospitalizations • So, is pharmacology important to your work? • Additionally, 5% of hospitalized patient experience an ADE during their stay • High risk: Anticoagulants, Opioids, Insulin, Cardiac, and Transitions of Care Adverse Drug Events, cont. • Elderly are more susceptible • Pediatrics patients more susceptible (weight-based dosing), especially liquids • Caregivers and patients admittedly
    [Show full text]
  • Physiology, Biochemistry, and Pharmacology of Transporters for Organic Cations
    International Journal of Molecular Sciences Editorial Physiology, Biochemistry, and Pharmacology of Transporters for Organic Cations Giuliano Ciarimboli Experimental Nephrology, Department of Internal Medicine D, University Hospital Münster, 48149 Münster, Germany; [email protected] This editorial summarizes the 13 scientific papers published in the Special Issue “Physiology, Biochemistry, and Pharmacology of Transporters for Organic Cations” of the International Journal of Molecular Sciences. In this Special Issue, the readers will find integrative information on transporters for organic cations. Besides reviews on physi- ology, pharmacology, and toxicology of these transporters [1–3], which offer a concise overview of the field, the readers will find original research work focusing on specific transporter aspects. Specifically, the review “Organic Cation Transporters in Human Physiology, Phar- macology, and Toxicology” by Samodelov et al. [1] summarizes well the general as- pects of physiology, pharmacology, and toxicology of transporter for organic cations. The other review “Organic Cation Transporters in the Lung—Current and Emerging (Patho)Physiological and Pharmacological Concepts” by Ali Selo et al. [2] focuses on these aspects of transporters for organic cations in the lung, an important but often ne- glected field. In the paper “Systems Biology Analysis Reveals Eight SLC22 Transporter Subgroups, Including OATs, OCTs, and OCTNs”, by performing a system biology analysis of SLC22 transporters, Engelhart et al. [4] suggest the existence of a transporter–metabolite network. They propose that, in this network, mono-, oligo-, and multi-specific SLC22 transporters Citation: Ciarimboli, G. Physiology, interact to regulate concentrations and fluxes of many metabolites and signaling molecules. Biochemistry, and Pharmacology of In particular, the organic cation transporters (OCT) subgroup seems to be associated with Transporters for Organic Cations.
    [Show full text]
  • Protein Identification Strategies in MALDI Imaging Mass Spectrometry
    Available online at www.sciencedirect.com ScienceDirect Protein identification strategies in MALDI imaging mass spectrometry: a brief review 1,2 1,2,3 Daniel J Ryan , Jeffrey M Spraggins and 1,2,3,4,5 Richard M Caprioli Matrix assisted laser desorption/ionization (MALDI) imaging specimens [1,2 ,3,4]. MALDI IMS allows for the label- mass spectrometry (IMS) is a powerful technology used to free, multiplex analysis of thousands of analytes across a investigate the spatial distributions of thousands of molecules samples surface yielding 2-dimensional molecular maps throughout a tissue section from a single experiment. As that elucidate both the localization and relative abundance proteins represent an important group of functional molecules of endogenous species. The technology has been used to in tissue and cells, the imaging of proteins has been an study awiderangeofanalyteclasses,includingmetabolites, important point of focus in the development of IMS drugs, lipids, peptides, and proteins [5,6 ,7 ,8]. The imag- technologies and methods. Protein identification is crucial for ing of proteins has garnered particular attention due to the the biological contextualization of molecular imaging data. role the proteins play in cellular processes [9], and because However, gas-phase fragmentation efficiency of MALDI MALDI IMS allows for the visualization of a protein and its generated proteins presents significant challenges, making various proteoforms (i.e. varying post-translational modifi- protein identification directly from tissue difficult. This review cations) in a single imaging experiment [10,11 ,12]. As highlights methods and technologies specifically related to highlighted in Figure 1, MALDI IMS is performed by first protein identification that have been developed to overcome coating a tissue section with a MALDI matrix, which assists these challenges in MALDI IMS experiments.
    [Show full text]
  • Suppression of Matrix Ions by N-Phosphorylation Labeling Using
    Electronic Supplementary Material (ESI) for Chemical Communications This journal is © The Royal Society of Chemistry 2012 Supporting Information Suppression of Matrix Ions by N-Phosphorylation Labeling Using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry Xiang Gao,a, b Zhi Tang,a Minghua Lu,a Hongxia Liu,b Yuyang Jiang,b Yufen Zhao c and Zongwei Cai*, a, b a Department of Chemistry, Hong Kong Baptist University, Kowloon Tong, Hong Kong, SAR, China b The Key Laboratory for Cancer Metabolomics of Shenzhen, Graduate School at Shenzhen, Tsinghua University, Shenzhen, 518055, China c Department of Chemistry and The Key Laboratory for Chemical Biology of Fujian Province, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen, 361005, P. R. China * Corresponding author. E-mail: [email protected]. 1 Electronic Supplementary Material (ESI) for Chemical Communications This journal is © The Royal Society of Chemistry 2012 EXPERIMENTAL SECTION Materials and Reagents. L-Amino acids, D-(+)-glucosamine hydrochloride, agmatine sulfate salt, formic acid, magnesium sulfate (MgSO4), trifluoroacetic acid (TFA), triethylamine (TEA), tetrachloromethane (CCl4), -cyano-4-hydroxycinnamic acid (CHCA), and 2, 5-dihydroxybenzoic acid (DHB) were purchased from Sigma (St. Louis, MO, USA) and used without further purification. Diisopropyl phosphate (DIPP-H) and anhydrous ethanol were obtained from Alfa Aesar Chemical Ltd. (Tianjin, China). Peptide calibration standard used for calibration of MALDI-MS instrument was obtained from Bruker Daltonics (Bruker, Germany). Sep-Pak Vac C18 cartridges were purchased from Waters (MA, USA). Porous graphitic carbon (PGC) cartridges were obtained from Alltech Associates, Inc. (Deerfield, IL). Graphene nonopowder (8 nm flakes) was obtained from Graphene Laboratories Inc.
    [Show full text]
  • 110499 Calcium-Antagonist Drugs
    DRUG THERAPY Review Article Drug Therapy smooth muscle (arteriolar and venous), nonvascular smooth muscle (bronchial, gastrointestinal, genitouri- nary, and uterine), and noncontractile tissues (pan- A LASTAIR J.J. WOOD, M.D., Editor creas, pituitary, adrenal glands, salivary glands, gastric mucosa, white cells, platelets, and lacrimal tissue). Blockade of L-type channels in vascular tissues results CALCIUM-ANTAGONIST DRUGS in the relaxation of vascular smooth muscle and in cardiac tisssue results in a negative inotropic effect. DARRELL R. ABERNETHY, M.D., PH.D., The ability of these drugs to decrease smooth-muscle AND JANICE B. SCHWARTZ, M.D. and myocardial contractility results in both clinically desirable antihypertensive and antianginal effects and undesirable myocardial depression. RUGS classified as calcium antagonists or Other calcium channels with electrophysiologic calcium-channel blockers were introduced properties have also been identified. These channels, into clinical medicine in the 1960s and are to which the calcium antagonists do not bind, in- D clude the N-type channels in neuronal tissue, P-type now among the most frequently prescribed drugs for the treatment of cardiovascular diseases.1 Although channels in Purkinje tissues, and T-type (transient potential) channels in cardiac nodal structures and the currently available calcium antagonists are chem- 4,5 ically diverse, they share the common property of vascular smooth muscle. blocking the transmembrane flow of calcium ions Regulation of the L-type channels may differ in through voltage-gated L-type (slowly inactivating) different types of cells. In cardiac myocytes, these channels.2 These drugs have proved effective in pa- channels are activated by catecholamines and other stimuli that activate adenylyl cyclase or cyclic aden- tients with hypertension, angina pectoris, and cardi- 6-8 ac arrhythmias and may be beneficial in patients with osine monophosphate–dependent protein kinase.
    [Show full text]